15 Minute News 15 Minute Fun
Follow Us
Sign In
Sign In
to Comment, Vote &
Create Storyboards.
Doctors have successfully treated an infant with a rare childhood leukemia using a targeted therapy approved for adults with inoperable liver cancer and advanced kidney cancer. The decision to use the drug, sorafenib, was made after pathologists identified a unique mutation of two genes being fused together instead of on separate chromosomes.
0
views
0
likes
0
dislikes


Storyboard
Print


Share this Article



Similar Articles
Comments


Please Sign In to comment


##username##
##datetime##
##comment##
##commentlikeno##Likes
##commentdislikeno##Dislikes




Terms & Conditions | About | Enquiries | Advertise